Pakistan Warns Novartis, Other Pharmas Against Calling Drugs 'Halal'
This article was originally published in PharmAsia News
Pakistan authorities have warned drug makers, particularly Novartis AG, that they cannot use the word "halal" in their advertisements
You may also be interested in...
T-knife, a developer of T-cell receptors intended for T-cell therapy in solid tumor cancers, says the series A gives its development program three years of financial runway.
A selection of articles you might have missed from July 2020, including exclusive interviews with industry leaders and a review of Q2 financing statistics.
Despite leading multinational pharma firms including AstraZeneca again delivering double-digit growth in China, the impact of coronavirus and an expanding volume-based purchasing scheme begin to surface.